Xilio Therapeutics, Inc. · NASDAQ:XLO
Stempoint Capital LP reported a 9.50% stake in Xilio Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Stempoint Capital LP reported a 9.50% stake in Xilio Therapeutics, Inc., 628,866 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 9.50%
- Shares
- 628,866
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| StemPoint Capital LP | 9.50% | 628,866 |
| StemPoint Capital Management GP LLC | 9.50% | 628,866 |
| Michelle Ross | 9.50% | 628,866 |